FDA Adverse Event
Injury
Summary report: N
RADIESSE
MDR report key: 14376521
·
Received May 11, 2022
Report
- Report Number
- MW5109659
- Event Type
- Injury
- Date Received
- May 11, 2022
- Date of Event
- April 28, 2022
- Report Date
- May 9, 2022
- Manufacturer
- MERZ NORTH AMERICA, INC.
- Product Code
- PKY
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
INFLAMMATORY REACTION POST DERMAL FILLER. ONE (1) SYRINGE OF RADIESSE FILLER TO THE DORSUM OF EACH HAND. EACH SYRINGE WAS MIXED / DILUTED WITH 1CC OF LIDOCAINE; 7 DAYS LATER, THE PT REPORTED REDNESS AND ITCHING. EXAM SHOWED INFLAMMATION, AND ACCUMULATION OF PURULENT FLUID WHICH REQUIRED I+D.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2504718 | RADIESSE | IMPLANT, DERMAL, FOR AESTHETIC USE IN THE HANDS | PKY | MERZ NORTH AMERICA, INC. | A000449930 | ||
| 2504719 | RADIESSE | IMPLANT, DERMAL, FOR AESTHETIC USE IN THE HANDS | PKY | MERZ NORTH AMERICA, INC. | A000449930 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Female | Other | 1% LIDOCAINE WITH | EPINEPHRINE XYLOCAINE| FRESENIUS KABI |